{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:29:37Z","timestamp":1765960177838,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lymphomas are ranked as the fifth most common cancer in Lebanon. There is concern about the need of information regarding the prevalence of lymphoid neoplasm particularly Non-Hodgkin lymphoma (NHL) subtypes in the Lebanese population. This study intended to establish a descriptive status of NHL histological subtypes distribution in Lebanon thus identifying the most common types, knowing that the literature is poor regarding the distribution of lymphoid malignancies particularly NHLs in Lebanon.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A bicenter retrospective descriptive study was performed. Patients aged above 18, diagnosed with NHL between January 1984 and March 2019 and registered in two Lebanese Medical centers were included in this study; 699 medical files were reviewed and the baseline characteristics of the disease were collected. Histological classification was based on the Working Formulation (WF) and World Health Organization (WHO) classification systems, whereas staging was based on the Ann Arbor system. Disease status was monitored with imaging studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age at diagnosis was 53.52\u2009\u00b1\u200917.46\u2009years in the studied population, with 380 (54.4%) males and 319 (45.6%) females. B-cell lymphoma (BCL) accounted for 86.3% while T-cell neoplasms accounted for 13.7%. The most common subtype was diffuse large B-cell lymphoma (DLBCL) (54%) followed by follicular lymphoma (FL) (17.2%). Mantle cell lymphoma (MCL) represented 3% of all BCL and small lymphocytic lymphoma (SLL) comprised less than 2%. Mucosa-associated lymphoid tissue (MALT) and Burkitt\u2019s lymphomas represented 3 and 1.7% respectively. 36.5% of the patients had extranodal disease at diagnosis. High-grade tumor represented 80.1% with 33.1% stage IV disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These observations indicate that the epidemiological patterns of NHLs in Lebanon were comparable to Western countries. Aggressive lymphomas account for the majority of NHLs in Lebanon.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11840-3","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:10:09Z","timestamp":1633896609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019"],"prefix":"10.1186","volume":"21","author":[{"given":"Elsie","family":"Touma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leony","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-5689","authenticated-orcid":false,"given":"Souheil","family":"Hallit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radwan","family":"El Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"14","key":"11840_CR1","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.7314\/APJCP.2014.15.14.5825","volume":"15","author":"C Sader-Ghorra","year":"2014","unstructured":"Sader-Ghorra C, Rassy M, Naderi S, Kourie HR, Kattan J. Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev. 2014;15(14):5825\u20138. https:\/\/doi.org\/10.7314\/APJCP.2014.15.14.5825.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"11840_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1478-7954-12-4","volume":"12","author":"A Shamseddine","year":"2014","unstructured":"Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003\u20132008 and projections until 2018. Popul Health Metrics. 2014;12(1):4. https:\/\/doi.org\/10.1186\/1478-7954-12-4.","journal-title":"Popul Health Metrics"},{"issue":"1","key":"11840_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000447577","volume":"91","author":"R Nair","year":"2016","unstructured":"Nair R, Arora N, Mallath MK. Epidemiology of non-Hodgkin\u2019s lymphoma in India. Oncology. 2016;91(1):18\u201325. https:\/\/doi.org\/10.1159\/000447577.","journal-title":"Oncology"},{"issue":"1","key":"11840_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/ijmpo.ijmpo_36_17","volume":"39","author":"DS Sandhu","year":"2018","unstructured":"Sandhu DS, Sharma A, Kumar L. Non-Hodgkin\u2019s lymphoma in northern India: an analysis of clinical features of 241 cases. Indian J Med Paediatr Oncol. 2018;39(1):42\u20135. https:\/\/doi.org\/10.4103\/ijmpo.ijmpo_36_17.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"9378","key":"11840_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0140-6736(03)13868-8","volume":"362","author":"LS Evans","year":"2003","unstructured":"Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2003;362(9378):139\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(03)13868-8.","journal-title":"Lancet"},{"issue":"9844","key":"11840_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380(9844):848\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(12)60605-9.","journal-title":"Lancet"},{"issue":"12","key":"11840_CR7","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1080\/21645515.2018.1508624","volume":"14","author":"JML Casan","year":"2018","unstructured":"Casan JML, Wong J, Northcott MJ, Opat S. Anti-CD20 monoclonal antibodies: reviewing a revolution. Hum Vaccin Immunother. 2018;14(12):2820\u201341. https:\/\/doi.org\/10.1080\/21645515.2018.1508624.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"11840_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","volume":"84","author":"AMS M\u00fcller","year":"2005","unstructured":"M\u00fcller AMS, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin\u2019s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84(1):1\u201312. https:\/\/doi.org\/10.1007\/s00277-004-0939-7.","journal-title":"Ann Hematol"},{"key":"11840_CR9","unstructured":"Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975\u20132002. ed. Bethesda: National Cancer Institute; 2005."},{"key":"11840_CR10","unstructured":"El-Attar IA. Cancer databases in the Arab world. Ethn Dis. 2005;15(1 Suppl 1):S1-3-4."},{"issue":"5","key":"11840_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"A Miranda-Filho","year":"2019","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Znaor A, Marcos-Gragera R, Steliarova-Foucher E, Bray F. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control. 2019;30(5):489\u201399. https:\/\/doi.org\/10.1007\/s10552-019-01155-5.","journal-title":"Cancer Causes Control"},{"key":"11840_CR12","doi-asserted-by":"publisher","unstructured":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: summary and description of a working formulation for clinical usage. The non-Hodgkin\u2019s lymphoma pathologic classification project. Cancer. 1982;49(10):2112\u201335. https:\/\/doi.org\/10.1002\/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2.","DOI":"10.1002\/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2"},{"key":"11840_CR13","unstructured":"Zerbini MCN, Soares FA, Paes RP. World Health Organization classification of tumors of hematopoietic and lymphoid tissues, 4th edition, 2008 \u2013 major changes from the 3rd edition, 200. Rev Assoc Med Bras. 2008;8:7."},{"issue":"6","key":"11840_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO. Staging Non-Hodgkin Lymphoma. CA Cancer J Clin. 2005;55(6):368\u201376. https:\/\/doi.org\/10.3322\/canjclin.55.6.368.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"11840_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/aje\/kwn119","volume":"168","author":"JS Lee","year":"2008","unstructured":"Lee JS, Bracci PM, Holly EA. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am J Epidemiol. 2008;168(3):278\u201388. https:\/\/doi.org\/10.1093\/aje\/kwn119.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"11840_CR16","doi-asserted-by":"publisher","first-page":"e0038","DOI":"10.5041\/RMMJ.10172","volume":"5","author":"N Horesh","year":"2014","unstructured":"Horesh N, Horowitz NA. Does gender matter in non-Hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038. https:\/\/doi.org\/10.5041\/RMMJ.10172.","journal-title":"Rambam Maimonides Med J"},{"issue":"7","key":"11840_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/leu.2011.68","volume":"25","author":"K Yakimchuk","year":"2011","unstructured":"Yakimchuk K, Iravani M, Hasni MS, Rh\u00f6nnstad P, Nilsson S, Jondal M, et al. Effect of ligand-activated estrogen receptor beta on lymphoma growth in vitro and in vivo. Leukemia. 2011;25(7):1103\u201310. https:\/\/doi.org\/10.1038\/leu.2011.68.","journal-title":"Leukemia."},{"issue":"10","key":"11840_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","volume":"101","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN, MacLennan KA, Muller-Hermelink HK, Bast M, et al. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica. 2016;101(10):1244\u201350. https:\/\/doi.org\/10.3324\/haematol.2016.148809.","journal-title":"Haematologica."},{"issue":"5","key":"11840_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0277-9536(96)00115-3","volume":"43","author":"CM Gijsbers van Wijk","year":"1996","unstructured":"Gijsbers van Wijk CM, van Vliet KP, Kolk AM. Gender perspectives and quality of care: towards appropriate and adequate health care for women. Soc Sci Med. 1996;43(5):707\u201320. https:\/\/doi.org\/10.1016\/0277-9536(96)00115-3.","journal-title":"Soc Sci Med"},{"issue":"3","key":"11840_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5144\/0256-4947.1994.187","volume":"14","author":"OM Koriech","year":"1994","unstructured":"Koriech OM. Al-Kuhaymi Rashid. Profile of Cancer in Riyadh armed forces hospital. Annals of Saudi Medicine. 1994;14(3):187\u201394. https:\/\/doi.org\/10.5144\/0256-4947.1994.187.","journal-title":"Annals of Saudi Medicine"},{"key":"11840_CR21","volume-title":"Western Asia to the Middle East to Northern Africa","author":"NM Almasri","year":"2003","unstructured":"Almasri NM, Habashneh MA, Khalidi HS. Western Asia to the Middle East to Northern Africa; 2003."},{"issue":"5","key":"11840_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.cej.0000243858.91642.c9","volume":"16","author":"MM Abdel-Fattah","year":"2007","unstructured":"Abdel-Fattah MM, Yassine OG. Non-Hodgkin\u2019s lymphomas in Alexandria, Egypt; incidence rates and trend study (1995\u20132004). Eur J Cancer Prev. 2007;16(5):479\u201385. https:\/\/doi.org\/10.1097\/01.cej.0000243858.91642.c9.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"11840_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/hon.2392","volume":"36","author":"T Intragumtornchai","year":"2018","unstructured":"Intragumtornchai T, Bunworasate U, Wudhikarn K, Lekhakula A, Julamanee J, Chansung K, et al. Non-Hodgkin lymphoma in South East Asia: an analysis of the histopathology, clinical features, and survival from Thailand. Hematol Oncol. 2018;36(1):28\u201336. https:\/\/doi.org\/10.1002\/hon.2392.","journal-title":"Hematol Oncol"},{"key":"11840_CR24","unstructured":"Lymphoma Action | T-cell lymphomas. Lymphoma Action. https:\/\/lymphoma-action.org.uk\/types-lymphoma-non-hodgkin-lymphoma\/t-cell-lymphomas"},{"issue":"3","key":"11840_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.respe.2009.02.204","volume":"57","author":"X Troussard","year":"2009","unstructured":"Troussard X, Duchenet V, Cornet E, Mouchel D, Malet M, Collignon A. \u00c9pid\u00e9miologie des h\u00e9mopathies malignes en Basse-Normandie. Rev Epidemiol Sante Publique. 2009;57(3):151\u20138. https:\/\/doi.org\/10.1016\/j.respe.2009.02.204.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"11840_CR26","unstructured":"Types of T-cell Lymphoma. https:\/\/www.cancer.org\/cancer\/non-hodgkin-lymphoma\/about\/t-cell-lymphoma.html"},{"issue":"1","key":"11840_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"Q-P Yang","year":"2011","unstructured":"Yang Q-P, Zhang W-Y, Yu J-B, Zhao S, Xu H, Wang WY, et al. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011;6(1):77. https:\/\/doi.org\/10.1186\/1746-1596-6-77.","journal-title":"Diagn Pathol"},{"issue":"3","key":"11840_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1827.2007.02207.x","volume":"58","author":"R Aoki","year":"2008","unstructured":"Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006. Pathol Int. 2008;58(3):174\u201382. https:\/\/doi.org\/10.1111\/j.1440-1827.2007.02207.x.","journal-title":"Pathol Int"},{"issue":"4","key":"11840_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12253-013-9634-0","volume":"19","author":"ZK Otrock","year":"2013","unstructured":"Otrock ZK, Saab J, Aftimos G, Nasr F, Farhat FS, Khairallah S, et al. A collaborative Nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses. Pathol Oncol Res. 2013;19(4):715\u201322. https:\/\/doi.org\/10.1007\/s12253-013-9634-0.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"11840_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3109\/10428194.2014.939967","volume":"56","author":"N Boudjerra","year":"2015","unstructured":"Boudjerra N, Perry AM, Audouin J, Diebold J, Nathwani BN, MacLennan KA, et al. Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification. Leuk Lymphoma. 2015;56(4):965\u201370. https:\/\/doi.org\/10.3109\/10428194.2014.939967.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"11840_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bjc.2015.94","volume":"112","author":"A Smith","year":"2015","unstructured":"Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, et al. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK\u2019s Haematological malignancy research network. Br J Cancer. 2015;112(9):1575\u201384. https:\/\/doi.org\/10.1038\/bjc.2015.94.","journal-title":"Br J Cancer"},{"issue":"4","key":"11840_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536\u201345. https:\/\/doi.org\/10.1111\/bjh.12659.","journal-title":"Br J Haematol"},{"issue":"5","key":"11840_CR33","first-page":"677","volume":"30","author":"SS Akhtar","year":"2009","unstructured":"Akhtar SS, Haque I, Wafa SM, El-Saka H, Saroor AM, Nadrah HM. Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification. Saudi Med J. 2009;30(5):677\u201381.","journal-title":"Saudi Med J"},{"issue":"5","key":"11840_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.canep.2009.09.006","volume":"33","author":"X-C Wu","year":"2009","unstructured":"Wu X-C, Andrews P, Chen VW, Groves FD. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians\/Pacific islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 2009;33(5):337\u201346. https:\/\/doi.org\/10.1016\/j.canep.2009.09.006.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"11840_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.canrad.2009.07.005","volume":"13","author":"L Quero","year":"2009","unstructured":"Quero L, Hennequin C, Brice P. Place de la radioth\u00e9rapie dans le traitement des lymphomes non hodgkiniens. Cancer\/Radioth\u00e9rapie. 2009;13(6):471\u20138. https:\/\/doi.org\/10.1016\/j.canrad.2009.07.005.","journal-title":"Cancer\/Radioth\u00e9rapie."},{"key":"11840_CR36","doi-asserted-by":"publisher","unstructured":"Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol. 2011;100(1):86\u201392. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013.","DOI":"10.1016\/j.radonc.2011.05.013"},{"issue":"1","key":"11840_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM199807023390104","volume":"339","author":"TP Miller","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma. N Engl J Med. 1998;339(1):21\u20136. https:\/\/doi.org\/10.1056\/NEJM199807023390104.","journal-title":"N Engl J Med"},{"issue":"1","key":"11840_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-107-1-25","volume":"107","author":"JM Connors","year":"1987","unstructured":"Connors JM, Klimo P, Fairey RN, Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med. 1987;107(1):25\u201330. https:\/\/doi.org\/10.7326\/0003-4819-107-1-25.","journal-title":"Ann Intern Med"},{"issue":"27","key":"11840_CR39","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2009.27.3441","volume":"28","author":"J Phan","year":"2010","unstructured":"Phan J, Mazloom A, Jeffrey Medeiros L, Zreik TG, Wogan C, Shihadeh F, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. JCO. 2010;28(27):4170\u20136. https:\/\/doi.org\/10.1200\/JCO.2009.27.3441.","journal-title":"JCO."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11840-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:12:55Z","timestamp":1633896775000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11840"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11840-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Faculty of Medicine at the Holy Spirit University of Kaslik ethics and research Committee approved this study protocol. A written consent was obtained from the patients before starting the data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1820"}}